31462-56-3

Usage

Uses

Used in Pharmaceutical Research and Drug Development:
Pyrimidine, 4-bromo(8CI,9CI) is utilized as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure and bromine substitution make it a valuable building block for the development of new drugs with specific therapeutic properties. Researchers in the pharmaceutical industry leverage its chemical reactivity and structural features to design and optimize drug candidates for a range of medical conditions.
Used in Organic Synthesis:
In the field of organic chemistry, Pyrimidine, 4-bromo(8CI,9CI) serves as a versatile starting material for the synthesis of other organic compounds. Its bromine atom can be replaced with other functional groups through various chemical reactions, enabling the creation of a diverse array of molecules with different properties and applications. Pyrimidine, 4-bromo(8CI,9CI) is particularly useful for the synthesis of complex organic molecules and the development of novel chemical entities.
Used in Chemical Research:
Pyrimidine, 4-bromo(8CI,9CI) is also employed as a research tool in chemical studies. Its unique structure and reactivity provide insights into the fundamental principles of organic chemistry and help researchers explore new reaction pathways and mechanisms. Pyrimidine, 4-bromo(8CI,9CI) can be used to investigate the effects of bromine substitution on the properties and behavior of pyrimidine derivatives, contributing to a deeper understanding of the structure-activity relationships in this class of compounds.
It is crucial for researchers and professionals in the chemical and pharmaceutical industries to handle and use Pyrimidine, 4-bromo(8CI,9CI) with proper safety precautions and in accordance with relevant regulations to ensure the safe and effective application of Pyrimidine, 4-bromo- (8CI,9CI) in various fields.

InChI:InChI=1/C4H3BrN2/c5-4-1-2-6-3-7-4/h1-3H

Upstream product

• 51953-18-5 pyrimidine-4(3H)-one 
• 51953-17-4 Pyrimidin-4-ol 

Downstream Products

• 723341-85-3 4-[(1-methyl-4-phenyl-1H-imidazol-5-yl)ethynyl]pyrimidine 
• 64660-82-8 4-benzylpyrimidine 
• 337461-35-5 4-(4-methylthiobenzylo)pyrimidine 
• 337461-34-4 4-(4-methoxybenzyl)pyrimidine 
• 1353577-63-5 4-(4-fluorobenzyl)pyrimidine 
• 1353577-65-7 4-(3-methoxybenzyl)pyrimidine 
• 1353577-67-9 4-(3,4,5-trimethoxybenzyl)pyrimidine 
• 1353577-64-6 4-(2-methoxybenzyl)pyrimidine 
• 1353577-62-4 4-(2-fluorobenzyl)pyrimidine 
• 1353577-66-8 4-(2,5-dimethoxybenzyl)pyrimidine 
• 1577253-54-3 C₁₅H₁₂N₄O₂ 
• 1577253-12-3 C₁₁H₈N₄ 
• 53975-33-0 4-(4-bromophenyl)pyrimidine 

Relevant academic research and scientific papers

IMIDAZOPYRAZINONES, PYRAZOLOPYRIMIDINONES AND PYRAZOLOPYRIDINONES AS PDE1 INHIBITORS

The present invention provides compounds according to formula (I) below that are PDE1 enzyme inhibitors and their use as medicaments, in particular for the treatment of neurodegenerative disorders and psychiatric disorders. The present invention also provides pharmaceutical compositions comprising compounds of the invention and methods of treating disorders using the compounds of the invention.

THERAPEUTIC AGENTS

A compound of the Formula: (I) (A chemical formula should be inserted here-please see paper copy enclosed herewith) Formula: (I); for use as a Tie2 receptor tyrosine kinase inhibitor in a warm-blooded animal such as man.